<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00975728</url>
  </required_header>
  <id_info>
    <org_study_id>DermIng E0709</org_study_id>
    <nct_id>NCT00975728</nct_id>
  </id_info>
  <brief_title>High Total Antioxidant Capacity Products Added to Diet</brief_title>
  <official_title>High Total Antioxidant Capacity (TAC) Products Added to Diet: Clinical and Instrumental Evaluation of Their Effect on Skin Surface Parameters and on Photo-induced Acute Damage of the Skin (Double Blind Clinical Study vs Placebo)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Derming SRL</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Derming SRL</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the antioxidant activity on skin photo induced
      damage of a food supplement and its anti-age properties.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the antioxidant activity of the tested product the following clinical and
      instrumental evaluations will be performed:

        1. Evaluation of experimentally induced erythema inhibition: in basal conditions, before
           starting the assumption of the test product/placebo, and at T4, T8, T12, T16 weeks, each
           volunteer wll be exposed at the level of dorsal skin to six incremental doses of UVR
           (ultraviolet radiations mJ/cm2 ) in order to determine the MED (minimal erythema dose of
           unprotected skin). 20+/-4 hours after the UV exposure clinical and instrumental (optical
           densitometry) evaluations of skin erythema and photographic documentation (only on 16
           preselected cases) will be performed.

        2. Blood samples collection for the determination of the principal antioxidants
           concentration (for example: lutein, carotene, lycopene and E vitamin): at T0, T4, T8 and
           T12 blood samples (5 ml of venous blood) will be collected on each volunteer by the
           Medical Staff. The samples will be sent to an external laboratory for haematologic
           control task.

      To determine the anti-age properties of the tested product the following clinical and
      instrumental evaluations will be performed:

        1. Non Invasive, instrumental evaluation of principal skin parameters: epicutaneous pH,
           skin hydration (skin electrical capacitance), skin firmness (plastoelasticity), skin
           texture (skin surface irregularity index - FFT on skin replicas) measurements will be
           performed at T0 and T8 mono-laterally at level of volar forearm medium third, left or
           right side according to a previously defined randomization list.

        2. Clinical pictures with UV flash (Wood's light): at T0 and T8, 20 preselected cases of
           fairy skinned volunteers (selected on the basis of clinical ananmnesis regarding
           photosensitivity) will be submitted to the realization of clinical pictures at the level
           of the face using a special UV flash, able to highlight melanin spots, even if not yet
           visible at the naked eye.

      Moreover aim of the study is also to evaluate the best dosage of the beverage (1 or 2
      servings of 250 ml/a day).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Erythema evaluation (MED-optical densitometry)</measure>
    <time_frame>T0 (basal conditions), T4 and T8 (after 4 and 8 week-treatment), T12 and T16 (follow-up visits - 12 and 16 weeks after T0)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin evaluations (Skin texture - Hydration - Plastoelasticity - Epicutaneous pH)</measure>
    <time_frame>T0 and T8 for skin evaluations - T0, T4, T8 and T12 for blood analysis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination on blood samples of antioxidants diet components</measure>
    <time_frame>T0 and T8 for skin evaluations - T0, T4, T8 and T12 for blood analysis</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Group 1 Product 825 (2-servings day)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects drinking 2 servings day of Product 825 for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 1 Product 824 (2 servings-day)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects drinking 2 servings-day of Product 824 for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 Product 825 (1 serving-day)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects drinking 1 serving-day of Product 825 for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gruop 2 Product 824 (1 serving-day)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects drinking 1 serving-day of Product 824 for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Alixir - Pomegranate, apple and Açai drink / Placebo</intervention_name>
    <description>250 ml/day Alixir/Placebo for Group 2 for 8 weeks 500 ml/day Alixir/Placebo for Group 1 for 8 weeks</description>
    <arm_group_label>Group 1 Product 825 (2-servings day)</arm_group_label>
    <arm_group_label>Group 1 Product 824 (2 servings-day)</arm_group_label>
    <arm_group_label>Group 2 Product 825 (1 serving-day)</arm_group_label>
    <arm_group_label>Gruop 2 Product 824 (1 serving-day)</arm_group_label>
    <other_name>Barilla Alixir (code 824/825)</other_name>
    <other_name>Anti-oxidant drink</other_name>
    <other_name>Açai drink</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult volunteers of both sexes, between 30 and 60 years of age

          -  Phototype II or III ( Fitzpatrick's classification)

          -  Volunteers in a good general state of health in the Investigator opinion

          -  Volunteers not taking drugs or undergoing surgical procedure

          -  Volunteers who are giving a written informed consent

        Exclusion Criteria:

          -  pregnancy

          -  lactation

          -  smoking &gt;10 cigarettes per day

          -  drinking more then one glass of wine per day

          -  drinking super-alcoholics

          -  assumption of food supplement

          -  change in the normal habits in the last month

          -  participation in a similar study during the previous 3 months

          -  insufficient adhesion to the study protocol

          -  dermatological disease

          -  clinical and significant skin condition on the test area (e.g. lesions,
             scars,malformations)

          -  diabetes

          -  endocrine disease

          -  hepatic, renal or cardiac disorder

          -  cancer

          -  topical drugs or surgical procedure on the test areas during the previous 3 months

          -  systemic corticosteroids

          -  aspirin or non-steroid anti-inflammatory drugs (FANS)

          -  diuretic drugs

          -  antibiotics and chemotherapics

          -  psychotropic drugs

          -  retinoids

          -  psoralens

          -  cardiologic and vascular drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adele Sparavigna, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Derming SRL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>DermIng S.r.l</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.derming.com</url>
    <description>Investigator center</description>
  </link>
  <link>
    <url>http://www.barilla.it</url>
    <description>Sponsor</description>
  </link>
  <link>
    <url>http://www.biochimica.unibo.it/Biochimica/default.htm</url>
    <description>Haematological laboratory center</description>
  </link>
  <reference>
    <citation>Elsner P., Berardesca E., Maibach H. Bioengineering of the skin: Water and the stratum corneum CRC Press, Boca Raton, 1994; Fuga GC, Spina C, Cavallotti C, Di Palma A, Lombardi G, Marmo W Computerized reflected optical densitometry. A research on the colour of the skin - Journal of Applied Cosmetology, 8:91-110,1990; Cosmetic, Toiletry and Fragrance Association of South Africa (CFTA), The European Cosmetic Toiletry and Perfumery Association (COLIPA), Japan Cosmetic Industry Association (JCIA) International sun protection factor (SPF) test method; October 2002; ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: May 1996; Setaro M., Sparavigna A. Morphological Evaluation of Skin Surface by Fourier's Transform: A Study on the Phase and the Modulus</citation>
  </reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2009</study_first_submitted>
  <study_first_submitted_qc>September 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2009</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Adele Sparavigna</name_title>
    <organization>DermIng S.r.l.</organization>
  </responsible_party>
  <keyword>Anti-oxidant</keyword>
  <keyword>Açai</keyword>
  <keyword>Food supplement</keyword>
  <keyword>Sun protection</keyword>
  <keyword>Skin erythema prevention</keyword>
  <keyword>Anti-oxidant efficacy</keyword>
  <keyword>Anti-age efficacy</keyword>
  <keyword>Skin photo-induced damage protection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

